Matthew T. Rondina

Matthew T. Rondina, MD, MS

Languages spoken: English

Clinical Locations

Madsen Health Center

801-581-8000

  • Dr. Matthew Rondina is a Professor in the Departments of Internal Medicine and Pathology at the University of Utah. He is also the Director of Molecular Medicine at the University of Utah and is the Medical Director of the Thrombosis Service at the Salt Lake City Veteran’s Administration Health Center. Dr. Rondina's laboratory focuses on understanding how inflammatory stress alters platelets and megakaryocytes to orchestrate immunothrombosis. Major ongoing efforts are (1) to use innovative sequencing technologies to understand how gene expression in platelets is altered in response to inflammation; (2) to map gene expression changes to cell function and host responses; and (3) to determine the regulatory elements controlling gene expression and cellular functional responses.

    Specialties

    • Thrombotic Disorders

    Board Certification

    American Board of Internal Medicine (Internal Medicine)

  • Dr. Matthew Rondina is a Professor in the Departments of Internal Medicine and Pathology at the University of Utah. He is also the Director of Molecular Medicine at the University of Utah and is the Medical Director of the Thrombosis Service at the Salt Lake City Veteran’s Administration Health Center. Dr. Rondina's laboratory focuses on understanding how inflammatory stress alters platelets and megakaryocytes to orchestrate immunothrombosis. Major ongoing efforts are (1) to use innovative sequencing technologies to understand how gene expression in platelets is altered in response to inflammation; (2) to map gene expression changes to cell function and host responses; and (3) to determine the regulatory elements controlling gene expression and cellular functional responses.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Pathology -Adjunct
    Board Certification
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Graduate Training Clinical Investigation - University of Utah M.S.
    Internal Medicine - University of Utah Chief Medical Resident
    Residency Internal Medicine - University of Utah Health Sciences Center Resident
    Internal Medicine - University of Utah Health Sciences Center Intern
    Professional Medical Medicine - University of Utah Medical School M.D.
    Psychology - University of Utah B.S.
    Undergraduate Brigham Young University

    Selected Publications

    Journal Article

    1. Petrocelli JJ, McKenzie AI, de Hart NMMP, Reidy PT, Mahmassani ZS, Keeble AR, Kaput KL, Wahl MP, Rondina MT, Marcus RL, Welt CK, Holland WL, Funai K, Fry CS, Drummond MJ (2023). Disuse-induced muscle fibrosis, cellular senescence, and senescence-associated secretory phenotype in older adults are alleviated during re-ambulation with metformin pre-treatment. Aging Cell, 22(11), e13936.
    2. Siebert AE, Brake MA, Verbeek SC, Johnston AJ, Morgan AP, Cleuren AC, Jurek AM, Schneider CD, Germain DM, Battistuzzi FU, Zhu G, Miller DR, Johnsen JM, Pardo-Manuel de Villena F, Rondina MT, Westrick RJ (2023). Identification of genomic loci regulating platelet plasminogen activator inhibitor-1 in mice. J Thromb Haemost, 21(10), 2917-2928.
    3. Guo L, Jacob S, Manne BK, Kolawole EM, Guo S, Wang X, Murray D, Tugolukova EA, Portier I, Kosaka Y, Barba C, Rondina MT, Evavold B, Morley C, Bhatlekar S, Bray PF (2023). Actin-bundling protein L-plastin promotes megakaryocyte rigidity and dampens proplatelet formation. Haematologica.
    4. Sachetto ATA, Archibald SJ, Hisada Y, Rosell A, Havervall S, van Es N, Nieuwland R, Campbell RA, Middleton EA, Rondina MT, Thlin C, Mackman N (2023). Tissue factor activity of small and large extracellular vesicles in different diseases. Res Pract Thromb Haemost, 7(3), 100124.
    5. Nay I, Hutchinson D, ROndina M, Kim K, Kirkham A, Trujillo T, Tolley ND, Munger M (2023). Prospective, randomized, controlled, trial to assess ASA DOSing by Body Mass Index in HEalthy Volunteers (DOSE Study) . Pharmacotherapy, 215-225.
    6. Konstorum A, Mohanty S, Zhao Y, Melillo A, Vander Wyk B, Nelson A, Tsang S, Blevins TP, Belshe RB, Chawla DG, Rondina MT, Gill TM, Montgomery RR, Allore HG, Kleinstein SH, Shaw AC (2023). Platelet response to influenza vaccination reflects effects of aging. Aging Cell, 22(2), e13749.
    7. Manne BK, Campbell RA, Bhatlekar S, Ajanel A, Denorme F, Portier I, Middleton EA, Tolley ND, Kosaka Y, Montenont E, Guo L, Rowley JW, Bray PF, Jacob S, Fukanaga R, Proud C, Weyrich AS, Rondina MT (2022). MAPK-interacting kinase 1 regulates platelet production, activation, and thrombosis. Blood, 140(23), 2477-2489.
    8. Campbell RA, Manne BK, Banerjee M, Middleton EA, Ajanel A, Schwertz H, Denorme F, Stubben C, Montenont E, Saperstein S, Page L, Tolley ND, Lim DL, Brown SM, Grissom CK, Sborov DW, Krishnan A, Rondina MT (2022). IFITM3 regulates fibrinogen endocytosis and platelet reactivity in nonviral sepsis. J Clin Invest, 132(23).
    9. Schwertz H, Rowley JW, Portier I, Middleton EA, Tolley ND, Campbell RA, Eustes AS, Chen K, Rondina MT (2021). Human platelets display dysregulated sepsis-associated autophagy, induced by altered LC3 protein-protein interaction of the Vici-protein EPG5. Autophagy, 18(7), 1534-1550.
    10. McKenzie AI, Mahmassani ZS, Petrocelli JJ, de Hart NMMP, Fix DK, Ferrara PJ, LaStayo PC, Marcus RL, Rondina MT, Summers SA, Johnson JM, Trinity JD, Funai K, Drummond MJ (2022). Short-term exposure to a clinical dose of metformin increases skeletal muscle mitochondrial H(2)O(2) emission and production in healthy, older adults: A randomized controlled trial. Exp Gerontol, 163, 111804.
    11. Morrell CN, Mix D, Aggarwal A, Bhandari R, Godwin M, Owens P 3rd, Lyden SP, Doyle A, Krauel K, Rondina MT, Mohan A, Lowenstein CJ, Shim S, Stauffer S, Josyula VP, Ture SK, Yule DI, Wagner LE 3rd, Ashton JM, Elbadawi A, Cameron SJ (2021). Platelet olfactory receptor activation limits platelet reactivity and growth of aortic aneurysms. J Clin Invest, 132(9).
    12. Woller SC, Stevens SM, Kaplan D, Wang TF, Branch DW, Groat D, Wilson EL, Armbruster B, Aston VT, Lloyd JF, Rondina MT, Elliott CG (2021). Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv, 6(6), 1661-1670.
    13. Bhatlekar S, Jacob S, Tugolukova E, Manne BK, Kosaka Y, Loher P, OConnell RM, Planelles V, Rondina MT, Rigoutsos I, Bray PF (2022). Interferon α-induced SAMHD1 regulates human cultured megakaryocyte apoptosis and proplatelet formation. Haematologica, 107(2), 558-561.
    14. Kempker JA, Martin GS, Rondina MT, Cannon-Albright LA (2022). Evidence for an Inherited Contribution to Sepsis Susceptibility Among a Cohort of U.S. Veterans. Crit Care Explor, 4(1), e0603.
    15. Othman M, Baker AT, Gupalo E, Elsebaie A, Bliss CM, Rondina MT, Lillicrap D, Parker AL (2021). To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia. J Thromb Haemost, 19(11), 2845-2856.
    16. Sun S, Jin C, Si J, Lei Y, Chen K, Cui Y, Liu Z, Liu J, Zhao M, Zhang X, Tang F, Rondina MT, Li Y, Wang QF (2021). Single-cell analysis of ploidy and the transcriptome reveals functional and spatial divergency in murine megakaryopoiesis. Blood, 138(14), 1211-1224.
    17. Queisser KA, Mellema RA, Middleton EA, Portier I, Manne BK, Denorme F, Beswick EJ, Rondina MT, Campbell RA, Petrey AC (2021). COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction. JCI Insight, 6(17).
    18. Guo L, Shen S, Rowley JW, Tolley ND, Jia W, Manne BK, McComas KN, Bolingbroke B, Kosaka Y, Krauel K, Denorme F, Jacob SP, Eustes AS, Campbell RA, Middleton EA, He X, Brown SM, Morrell CN, Weyrich AS, Rondina MT (2020). Platelet MHC class I mediates CD8+ T-cell suppression during sepsis. Blood, 138(5), 401-416.
    19. Supernat A, Popda M, Pastuszak K, Best MG, Grener P, Veld SI, Siek B, Bednarz-Knoll N, Rondina MT, Stokowy T, Wurdinger T, Jassem J, aczek AJ (2021). Transcriptomic landscape of blood platelets in healthy donors. Sci Rep, 11(1), 15679.
    20. Trinity JD, Craig JC, Fermoyle CC, McKenzie AI, Lewis MT, Park SH, Rondina MT, Richardson RS (2021). Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study. J Appl Physiol (1985), 130(6), 1961-1970.
    21. Campbell RA, Hisada Y, Denorme F, Grover SP, Bouck EG, Middleton EA, Wolberg AS, Rondina MT, Mackman N (2021). Comparison of the coagulopathies associated with COVID-19 and sepsis. Res Pract Thromb Haemost, 5(4), e12525.
    22. Montenont E, Bhatlekar S, Jacob S, Kosaka Y, Manne BK, Lee O, Parra-Izquierdo I, Tugolukova E, Tolley ND, Rondina MT, Bray PF, Rowley JW (2020). CRISPR-edited megakaryocytes for rapid screening of platelet gene functions. Blood Adv, 5(9), 2362-2374.
    23. Sumanth MS, Jacob SP, Abhilasha KV, Manne BK, Basrur V, Lehoux S, Campbell RA, Yost CC, McIntyre TM, Cummings RD, Weyrich AS, Rondina MT, Marathe GK (2020). Different glycoforms of alpha-1-acid glycoprotein contribute to its functional alterations in platelets and neutrophils. J Leukoc Biol, 109(5), 915-930.
    24. Eustes AS, Campbell RA, Middleton EA, Tolley ND, Manne BK, Montenont E, Rowley JW, Krauel K, Blair A, Guo L, Kosaka Y, Medeiros-de-Moraes IM, Lacerda M, Hottz ED, Neto HCF, Zimmerman GA, Weyrich AS, Petrey A, Rondina MT (2021). Heparanase expression and activity are increased in platelets during clinical sepsis. J Thromb Haemost, 19(5), 1319-1330.
    25. Brown SM, Beesley SJ, Stubben C, Wilson EL, Presson AP, Grissom C, Maguire C, Rondina MT, Hopkins RO (2020). Postseptic Cognitive Impairment and Expression of APOE in Peripheral Blood: The Cognition After SepsiS (CASS) Observational Pilot Study. J Intensive Care Med, 36(3), 262-270.
    26. Granja MG, Alves LP, Leardini-Tristo M, Saul ME, Bortoni LC, de Moraes FM, Ferreira EC, de Moraes BPT, da Silva VZ, Dos Santos AFR, Silva AR, Gonalves-de-Albuquerque CF, Bambini-Junior V, Weyrich AS, Rondina MT, Zimmerman GA, de Castro-Faria-Neto HC (2021). Inflammatory, synaptic, motor, and behavioral alterations induced by gestational sepsis on the offspring at different stages of life. J Neuroinflammation, 18(1), 60.
    27. Griffiths TM, Page L, Weyrich AS, Rondina MT, Campbell RA (2020). Platelet electrical resistance for measuring platelet activation and adhesion in human health and disease. Thromb Res, 198, 204-209.
    28. Ross JE, Zhang BM, Lee K, Mohan S, Branchford BR, Bray P, Dugan SN, Freson K, Heller PG, Kahr WHA, Lambert MP, Luchtman-Jones L, Luo M, Perez Botero J, Rondina MT, Ryan G, Westbury S, Bergmeier W, Di Paola J (2020). Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel. Blood Adv, 5(2), 414-431.
    29. Zheng Y, Larragoite ET, Williams ESCP, Lama J, Cisneros I, Delgado JC, Slev P, Rychert J, Innis EA, Coiras M, Rondina MT, Spivak AM, Planelles V (2021). Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions. Virol J, 18(1), 1.
    30. Bouck EG, Denorme F, Holle LA, Middelton EA, Blair AM, de Laat B, Schiffman JD, Yost CC, Rondina MT, Wolberg AS, Campbell RA (2020). COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity. Arterioscler Thromb Vasc Biol, 41(1), 401-414.
    31. Melki I, Allaeys I, Tessandier N, Mailhot B, Cloutier N, Campbell RA, Rowley JW, Salem D, Zufferey A, Laroche A, Lvesque T, Patey N, Rauch J, Lood C, Droit A, McKenzie SE, Machlus KR, Rondina MT, Lacroix S, Fortin PR, Boilard E (2020). FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus. Blood, 136(25), 2933-2945.
    32. Trivedi S, Labuz D, Anderson CP, Araujo CV, Blair A, Middleton EA, Jensen O, Tran A, Mulvey MA, Campbell RA, Hale JS, Rondina MT, Leung DT (2020). Mucosal-associated invariant T (MAIT) cells mediate protective host responses in sepsis. Elife, 9.
    33. Denorme F, Manne BK, Portier I, Petrey AC, Middleton EA, Kile BT, Rondina MT, Campbell RA (2020). COVID-19 patients exhibit reduced procoagulant platelet responses. J Thromb Haemost, 18(11), 3067-3073.
    34. Bhatlekar S, Manne BK, Basak I, Edelstein LC, Tugolukova E, Stoller ML, Cody MJ, Morley SC, Nagalla S, Weyrich AS, Rowley JW, OConnell RM, Rondina MT, Campbell RA, Bray PF (2020). miR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastin. Blood, 136(15), 1760-1772.
    35. Frey C, Koliopoulou AG, Montenont E, Tolley ND, Javan H, McKellar SH, Drakos SG, Selzman CH, Rondina MT (2020). Longitudinal assessment of the platelet transcriptome in advanced heart failure patients following mechanical unloading. Platelets, 31(7), 952-959.
    36. Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, Petrey AC, Tolley ND, Guo L, Cody M, Weyrich AS, Yost CC, Rondina MT, Campbell RA (2020). Platelet gene expression and function in patients with COVID-19. Blood, 136(11), 1317-1329.
    37. Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, Mostyka M, Baxter-Stoltzfus A, Borczuk AC, Loda M, Cody MJ, Manne BK, Portier I, Harris ES, Petrey AC, Beswick EJ, Caulin AF, Iovino A, Abegglen LM, Weyrich AS, Rondina MT, Egeblad M, Schiffman JD, Yost CC (2020). Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood, 136(10), 1169-1179.
    38. Manne BK, Bhatlekar S, Middleton EA, Weyrich AS, Borst O, Rondina MT (2020). Phospho-inositide-dependent kinase 1 regulates signal dependent translation in megakaryocytes and platelets. J Thromb Haemost, 18(5), 1183-1196.
    39. Rondina MT, Voora D, Simon LM, Schwertz H, Harper JF, Lee O, Bhatlekar SC, Li Q, Eustes AS, Montenont E, Campbell RA, Tolley ND, Kosaka Y, Weyrich AS, Bray PF, Rowley JW (2019). Longitudinal RNA-Seq Analysis of the Repeatability of Gene Expression and Splicing in Human Platelets Identifies a Platelet SELP Splice QTL. Circ Res, 126(4), 501-516.
    40. Denorme F, Manne BK, Portier I, Eustes AS, Kosaka Y, Kile BT, Rondina MT, Campbell RA (2019). Platelet necrosis mediates ischemic stroke outcome in mice. Blood, 135(6), 429-440.
    41. Marini I, Rigoni F, Zlamal J, Pelzl L, Althaus K, Nowak-Harnau S, Rondina MT, Bakchoul T (2019). Blood donor-derived buffy coat to produce platelets in vitro. Vox Sang, 115(1), 94-102.
    42. Cirulis MM, Beesley SJ, Wilson EL, Stubben C, Olsen TD, Hirshberg EL, Smith LM, Lanspa MJ, Abraham TP, Grissom CK, Rondina MT, Brown SM (2019). The peripheral blood transcriptome in septic cardiomyopathy: an observational, pilot study. Intensive Care Med Exp, 7(1), 57.
    43. Montenont E, Rondina MT, Campbell RA (2019). Altered functions of platelets during aging. Curr Opin Hematol, 26(5), 336-342.
    44. Middleton EA, Rowley JW, Campbell RA, Grissom CK, Brown SM, Beesley SJ, Schwertz HOR, Kosaka Y, Manne BK, Krauel K, Tolley ND, Eustes AS, Guo L, Paine R 3rd, Harris E, Zimmerman GA, Weyrich AS, Rondina MT (2019). Sepsis Alters the Transcriptional and Translational Landscape of Human and Murine Platelets. Blood, 134(12), 911-923.
    45. Davizon-Castillo P, McMahon B, Aguila S, Bark D, Ashworth K, Allawzi A, Campbell RA, Montenont E, Nemkov T, DAlessandro A, Clendenen N, Shih L, Sanders NA, Higa K, Cox A, Padilla-Romo Z, Hernandez G, Wartchow E, Trahan GD, Nozik-Grayck E, Jones K, Pietras E, DeGregori J, Rondina MT, Di Paola J (2019). TNF-alpha driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging. Blood, 134(9), 727-740.
    46. Campbell RA, Schwertz H, Hottz ED, Rowley JW, Manne BK, Washington AV, Hunter-Mellado R, Tolley ND, Christensen M, Eustes AS, Montenont E, Bhatlekar S, Ventrone CH, Kirkpatrick BD, Pierce KK, Whitehead SS, Diehl SA, Bray PF, Zimmerman GA, Kosaka Y, Bozza PT, Bozza FA, Weyrich AS, Rondina MT (2019). Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3. Blood, 133(19), 2013-2026.
    47. Fidler TP, Marti A, Gerth K, Middleton EA, Campbell RA, Rondina MT, Weyrich AS, Abel ED (2019). Glucose Metabolism Is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes. Diabetes, 68(5), 932-938.
    48. Bhatlekar S, Basak I, Edelstein LC, Campbell RA, Lindsey CR, Italiano JE Jr, Weyrich AS, Rowley JW, Rondina MT, Sola-Visner M, Bray PF (2019). Anti-apoptotic BCL2L2 increases megakaryocyte proplatelet formation in cultures of human cord blood. Haematologica, 104(10), 2075-2083.
    49. Shang C, Wuren T, Ga Q, Bai Z, Guo L, Eustes AS, McComas KN, Rondina MT, Ge R (2019). The human platelet transcriptome and proteome is altered and pro-thrombotic functional responses are increased during prolonged hypoxia exposure at high altitude. Platelets, 1-10.
    50. Jessica MO, Fiorella R, Ocatavio S, Linnette R, Nahomy L, Kanth MB, Bismarck M, Rondina MT, Valance WA (2018). TLT-1-CONTROLS EARLY THROMBUS FORMATION AND STABILITY BY FACILITATING AIIBB3 OUTSIDE-IN SIGNALING IN MICE. Int J Adv Res (Indore), 6(3), 1143-1149.
    51. Rondina MT, Tatsumi K, Bastarache JA, Mackman N (2016). Microvesicle Tissue Factor Activity and Interleukin-8 Levels are Associated with Mortality in Patients with Influenza A/H1N1 Infection. Crit Care Med, 44(7), e574-8.
    52. Simeoni I, Stephens JC, Hu F, Deevi SV, Megy K, Bariana TK, Lentaigne C, Schulman S, Sivapalaratnam S, Vries MJ, Westbury SK, Greene D, Papadia S, Alessi MC, Attwood AP, Ballmaier M, Baynam G, Bermejo E, Bertoli M, Bray PF, Bury L, Cattaneo M, Collins P, Daugherty LC, Favier R, French DL, Furie B, Gattens M, Germeshausen M, Ghevaert C, Goodeve AC, Guerrero JA, Hampshire DJ, Hart DP, Heemskerk JW, Henskens YM, Hill M, Hogg N, Jolley JD, Kahr WH, Kelly AM, Kerr R, Kostadima M, Kunishima S, Lambert MP, Liesner R, Lopez JA, Mapeta RP, Mathias M, Millar CM, Nathwani A, Neerman-Arbez M, Nurden AT, Nurden P, Othman M, Peerlinck K, Perry DJ, Poudel P, Reitsma P, Rondina MT, Smethurst PA, Stevenson W, Szkotak A, Tuna S, van Geet C, Whitehorn D, Wilcox DA, Zhang B, Revel-Vilk S, Gresele P, Bellissimo DB, Penkett CJ, Laffan MA, Mumford AD, Rendon A, Gomez K, Freson K, Ouwehand WH, Turro E (2016). A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood, 127(23), 2791-803.
    53. Shih L, Kaplan D, Kraiss LW, Casper TC, Pendleton RC, Peters CL, Supiano MA, Zimmerman GA, Weyrich AS, Rondina MT (2016). Platelet-Monocyte Aggregates and C-Reactive Protein are Associated with VTE in Older Surgical Patients. Sci Rep, 6, 27478.
    54. Rondina MT, Freitag M, Pluthero FG, Kahr WH, Rowley JW, Kraiss LW, Franks Z, Zimmerman GA, Weyrich AS, Schwertz H (2016). Non-genomic activities of retinoic acid receptor alpha control actin cytoskeletal events in human platelets. J Thromb Haemost, 14(5), 1082-94.
    55. Woller SC, Stevens SM, Kaplan DA, Branch DW, Aston VT, Wilson EL, Gallo HM, Johnson EG, Rondina MT, Lloyd JF, Evans RS, Elliott CG (2016). Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS). Clin Appl Thromb Hemost, 22(3), 239-47.
    56. Rondina MT, Graves KK (2016). The addition of abdomen and pelvis CT to limited cancer screening does not increase diagnosis of cancer in patients with unprovoked venous thromboembolism. Evid Based Med, 21(1), 19.
    57. Stubblefield WB, Alves NJ, Rondina MT, Kline JA (2016). Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism. PLoS One, 11(2), e0148747.
    58. Su J, Li Z, Cui S, Ji L, Geng H, Chai K, Ma X, Bai Z, Yang Y, Wuren T, Ge RL, Rondina MT (2015). The Local HIF-2alpha/EPO Pathway in the Bone Marrow is Associated with Excessive Erythrocytosis and the Increase in Bone Marrow Microvessel Density in Chronic Mountain Sickness. High Alt Med Biol, 16(4), 318-30.
    59. Vazquez S, Rondina MT (2015). Direct oral anticoagulants (DOACs). Vasc Med, 20(6), 575-7.
    60. Watkins RD, Rondina MT (2015). ACP Journal Club. Review: DOACs do not differ from standard anticoagulants for recurrent VTE; factor Xa inhibitors reduce bleeding. Ann Intern Med, 163(8), JC3.
    61. Brown SM, Tate MQ, Jones JP, Kuttler KG, Lanspa MJ, Rondina MT, Grissom CK, Mathews VJ (2015). Coefficient of Variation of Coarsely Sampled Heart Rate is Associated With Early Vasopressor Independence in Severe Sepsis and Septic Shock. J Intensive Care Med, 30(7), 420-5.
    62. Stewart LK, Peitz GW, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Kline JA (2015). Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism. J Thromb Thrombolysis, 40(2), 161-6.
    63. Xu J, Yang YZ, Tang F, Ga Q, Wuren T, Wang Z, Ma L, Rondina MT, Ge RL (2015). CYP17A1 and CYP2E1 variants associated with high altitude polycythemia in Tibetans at the Qinghai-Tibetan Plateau. Gene, 566(2), 257-63.
    64. Rondina MT, Weyrich AS (2015). Dengue virus pirates human platelets. Blood, 126(3), 286-7.
    65. Rondina MT, Weyrich AS (2015). Regulation of the genetic code in megakaryocytes and platelets. J Thromb Haemost, 13 Suppl 1, S26-32.
    66. Brown SM, Grissom CK, Rondina MT, Hoidal JR, Scholand MB, Wolff RK, Morris AH, Paine R 3rd (2015). Polymorphisms in key pulmonary inflammatory pathways and the development of acute respiratory distress syndrome. Exp Lung Res, 41(3), 155-62.
    67. Franks Z, Carlisle M, Rondina MT (2015). Current challenges in understanding immune cell functions during septic syndromes. BMC Immunol, 16, 11.
    68. Edholm K, Ragle N, Rondina MT (2015). Antithrombotic management of atrial fibrillation in the elderly. Med Clin North Am, 99(2), 417-30.
    69. Zhao YX, Tang F, Ga Q, Wuren T, Wang YP, Rondina MT, Ge RL (2015). High fat diet exacerbates vascular endothelial dysfunction in rats exposed to continuous hypobaric hypoxia. Biochem Biophys Res Commun, 457(3), 485-91.
    70. Rondina MT, Carlisle M, Fraughton T, Brown SM, Miller RR 3rd, Harris ES, Weyrich AS, Zimmerman GA, Supiano MA, Grissom CK (2014). Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci, 70(2), 225-31.
    71. Madden JL, Drakos SG, Stehlik J, McKellar SH, Rondina MT, Weyrich AS, Selzman CH (2014). Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis. ASAIO J, 60(5), 524-8.
    72. Cook RM, Rondina MT, Horton DJ (2014). Rivaroxaban for the Long-term Treatment of Spontaneous Ovarian Vein Thrombosis Caused by Factor V Leiden Homozygosity. Ann Pharmacother, 48(8), 1055-1060.
    73. Rondina MT, Carlisle M, Fraughton T, Brown SM, Miller RR 3rd, Harris ES, Weyrich AS, Zimmerman GA, Supiano MA, Grissom CK (2014). Platelet-Monocyte Aggregate Formation and Mortality Risk in Older Patients With Severe Sepsis and Septic Shock. J Gerontol A Biol Sci Med Sci, 70(2), 225-231.
    74. Kline JA, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Hernandez J (2014). Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost, 12(4), 459-68.
    75. Johnson SA, Rondina MT (2014). Edoxaban was noninferior to warfarin for preventing stroke or systemic embolism in atrial fibrillation. Ann Intern Med, 160(6), JC7.
    76. Mohebali D, Kaplan D, Carlisle M, Supiano MA, Rondina MT (2014). Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults. J Am Geriatr Soc, 62(3), 529-35.
    77. Brown SM, Tate Q, Jones JP, Knox DB, Kuttler KG, Lanspa M, Rondina MT, Grissom CK, Behera S, Mathews VJ, Morris A (2013). Initial fractal exponent of heart rate variability is associated with success of early resuscitation in patients with severe sepsis or septic shock: a prospective cohort study. J Crit Care, 28(6), 959-63.
    78. Vazquez S, Rondina MT (2013). ACP Journal Club. Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF. Ann Intern Med, 159(2), JC8.
    79. Rondina MT, Weyrich AS, Zimmerman GA (2013). Platelets as cellular effectors of inflammation in vascular diseases. Circ Res, 112(11), 1506-19.
    80. Chen K, Rondina MT, Weyrich AS (2013). A sticky story for signal transducer and activator of transcription 3 in platelets. Circulation, 127(4), 421-3.
    81. Kraemer BF, Campbell RA, Schwertz H, Franks ZG, Vieira de Abreu A, Grundler K, Kile BT, Dhakal BK, Rondina MT, Kahr WH, Mulvey MA, Blaylock RC, Zimmerman GA, Weyrich AS (2012). Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood, 120(25), 5014-20.
    82. Rondina MT, Lam UT, Pendleton RC, Kraiss LW, Wanner N, Zimmerman GA, Hoffman JM, Hanrahan C, Boucher K, Christian PE, Butterfield RI, Morton KA (2012). (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis. Clin Nucl Med, 37(12), 1139-45.
    83. McInturff AM, Cody MJ, Elliott EA, Glenn JW, Rowley JW, Rondina MT, Yost CC (2012). Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 alpha. Blood, 120(15), 3118-25.
    84. Freeman A, Horner T, Pendleton RC, Rondina MT (2012). Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity. Am J Hematol, 87(7), 740-3.
    85. Rondina MT, Brewster B, Grissom CK, Zimmerman GA, Kastendieck DH, Harris ES, Weyrich AS (2012). In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest, 141(6), 1490-1495.
    86. Rondina MT, Grissom CK, Men S, Harris ES, Schwertz H, Zimmerman GA, Weyrich AS (2012). Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques. Thromb Res, 129(6), 729-35.
    87. Rondina MT, Wanner N, Pendleton RC, Kraiss LW, Vinik R, Zimmerman GA, Heilbrun M, Hoffman JM, Morton KA (2011). A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism. Thromb Res, 129(1), 22-7.
    88. Rondina MT, Weyrich AS (2012). Targeting phosphodiesterases in anti-platelet therapy. Handb Exp Pharmacol, (210), 225-38.
    89. Rondina MT, Schwertz H, Harris ES, Kraemer BF, Campbell RA, Mackman N, Grissom CK, Weyrich AS, Zimmerman GA (2011). The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost, 9(4), 748-58.
    90. Johnson S, Rondina MT (2011). Local INR control had some effect on the benefits of dabigatran over warfarin for major bleeding in atrial fibrillation. ACP J Club, 154(2), JC1-6.
    91. Vazquez S, Rondina MT (2010). ACP Journal Club. Review: Graduated compression stockings reduce deep venous thrombosis in hospitalized patients. Ann Intern Med, 153(12), JC6-6.
    92. Freeman AL, Pendleton RC, Rondina MT (2010). Prevention of venous thromboembolism in obesity. Expert Rev Cardiovasc Ther, 8(12), 1711-21.
    93. Franks ZG, Campbell RA, Weyrich AS, Rondina MT (2010). Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke. Ann N Y Acad Sci, 1207, 11-7.
    94. Vazquez SR, Johnson SA, Rondina MT (2010). Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thromb Res, 126(2), e69-77.
    95. Rondina MT, Walker A, Pendleton RC (2010). Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia. Hosp Pract (1995), 38(2), 19-28.
    96. Rondina MT, Wheeler M, Rodgers GM, Draper L, Pendleton RC (2009). Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients. Thromb Res, 125(3), 220-3.
    97. Rondina MT, Lapp JM, Carlquist JF, Muhlestein JB, Kolek MJ, Horne BD, Pearson RR, Anderson JL (2007). Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography. Cardiology, 109(3), 196-201.

    Review

    1. Mahamad S, Modi D, Al-Samkari H, Cuker A, Despotovic JM, Italiano JE, Lambert MP, Lee EJ, Rondina MT, Sholzberg M, Kruse C, Larch M, Nazy I, Miller MS, Arnold DM (2023). Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management. [Review]. Res Pract Thromb Haemost, 7(2), 100097.
    2. Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, Gralinski LE, Rondina MT, van de Veerdonk FL, Hoffmeister KM, Griffin JH, Nugent D, Moon K, Morrissey JH (2022). Understanding COVID-19-associated coagulopathy. [Review]. Nat Rev Immunol, 22(10), 639-649.
    3. Campbell RA, Boilard E, Rondina MT (2020). Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? [Review]. J Thromb Haemost, 19(1), 46-50.
    4. Davizon-Castillo P, Rowley JW, Rondina MT (2020). Megakaryocyte and Platelet Transcriptomics for Discoveries in Human Health and Disease. [Review]. Arterioscler Thromb Vasc Biol, 40(6), 1432-1440.
    5. Trunk AD, Rondina MT, Kaplan DA (2019). Venous Thromboembolism at High Altitude: Our Approach to Patients at Risk. [Review]. High Alt Med Biol, 20(4), 331-336.
    6. Guo L, Rondina MT (2019). The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases. [Review]. Front Immunol, 10, 2204.

    Book Chapter

    1. Rondina MT, Weyrich AS (2012). Targeting Phosphodiesterases in Anti-Platelet Therapy. In Gresele, P. (Eds.), Antiplatelet Agents, Handbook of Experimental Pharmacology (210, pp. 225-38). Berlin: Springer-Verlag.
    2. Harris ES, Rondina MT, Schwertz H, Weyrich AS, Zimmerman GA (2010). Pathogenesis of sepsis and sepsis-induced acute lung injury. In A.M.K. Choi (Ed.), Acute Respiratory Distress Syndrome, Second Edition (pp. 369-419). Informa Healthcare.

    Editorial

    1. Rondina MT (2021). Editorial: special review series on viruses and platelets. Platelets, 33(2), 174-175.
    2. Denorme F, Rondina MT (2019). Targeting Glycoprotein VI for Thromboembolic Disorders. Arterioscler Thromb Vasc Biol, 39(5), 839-840.
    3. Schwertz H, Rondina MT (2016). Cdkn2a Orchestrates Platelet Production and Reactivity in Atherosclerosis. Circ Cardiovasc Genet, 9(3), 203-5.

    Abstract

    1. Rondina MT, Lam UT, Pendleton RC, Kraiss LW, Wanner N, Zimmerman GA, Hanrahan C Boucher K, Hoffman M, Morton KA (2012). The role of 18-fluorine-fluorodeoxyglucose positron emission tomography in the evaluation of deep vein thrombosis. [Abstract]. Thrombosis Research, 129(S1), S165.

    Other

    1. Othman M, Baker AT, Gupalo E, Elsebaie A, Bliss CM, Rondina MT, Lillicrap D, Parker AL (2023). Corrigendum to To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia [J Thromb Haemost. 2021 Nov;19(11):2845-2856. doi: 10.1111/jth.15485]. J Thromb Haemost (21(4), p. 1066). England.